Group 1 - The company, Guichuang Tongqiao, repurchased 50,000 shares at an average price of HKD 23.68 per share, totaling approximately HKD 1.1842 million, with a cumulative repurchase of 4.1145 million shares this year, representing 1.29% of the total share capital [1] - The recent stock repurchase activity may indicate management's confidence in the company's future development and belief that the current stock price is undervalued [1] - Stock buybacks are often viewed as a positive signal, potentially reducing the number of shares in circulation, thereby enhancing earnings per share and stock price [1] Group 2 - Guichuang Tongqiao is an innovative medical device company listed on the Hong Kong Stock Exchange, focusing on the research, production, and sales of peripheral vascular interventional medical devices [2] - The company aims to provide high-quality and innovative medical solutions, with products including balloon dilation catheters and stents, capturing a certain market share in the growing medical device industry [2] - The business development of Guichuang Tongqiao is closely linked to the increasing global demand for medical services, particularly in light of the rising attention to vascular diseases, indicating a broad market prospect for its products [2]
归创通桥回购5.00万股股票，共耗资约118.42万港元，本年累计回购411.45万股